D3D: Data, Drugs, Diagnostics
Next Generation Biobanking in a Targeted Outsourcing Model
The path to realizing the full potential of samples stored in biobanks - collected in the course of clinical trials, for example - has fast become a data problem requiring increasingly sophisticated approaches for management. Trials are global, increasingly externalized with multiple stakeholders, generate large amounts of data, and operate in an ever-changing regulatory landscape. Maintaining state-of-the-art, compliant approaches for data today and in the future requires expert partners for execution. In this Webinar, attendees will learn emerging best practices for Next Generation Biobanking as it is applied in clinical trial sample and consent tracking, specifically in a targeted outsourcing model.
Speakers:
Amelia Wall Warner, PharmD, RPh
Founder & CEO
Global Specimen Solutions, Inc (GSS)
Amelia is the Founder and CEO of Global Specimen Solutions, Inc (GSS)- an innovative specimen management CRO in Raleigh, NC. Amelia received her doctorate from University of North Carolina and completed residency and fellowship training at St Jude Children’s Research Hospital. She has over 15 years leadership experience in the pharmaceutical industry and academia including Head of Clinical Pharmacogenomics/ Clinical Specimen Management for Merck and Head of Pharmacogenomics for the Children’s Hospital of Philadelphia.
She has held numerous roles and won leadership awards including becoming an invited PhRMA representative to ICH E16 and Chair of the Industry Pharmacogenomics Working Group.
Jian Wang, Ph.D.
President & CEO
BioFortis, Inc.
Dr. Jian Wang received his Ph.D. in Bioengineering from the University of Washington in 1996. After a brief postdoctoral post at the Carnegie Mellon University, Jian joined the biotechnology industry - first with Cellomics (now part of Thermo Fisher Scientific) and then Physiome Sciences and Paradigm Genetics. Jian joined BioFortis in 2004 and became its President and CEO in 2005. Jian developed several commercial life science informatics products with customers in academia, government and the bio-pharmaceutical industry. He delights in helping his customers unleash the power of informatics to increase their productivity in scientific, clinical and translational research.
